Product Information
ALMOTRIPTAN MALATE 6.25 MG TAB is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $16.5091 per EA under NDC 00378524585. Its NADAC has been published 251 times since Oct 19, 2016.
FDA first approved this application on Nov 9, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
6.25 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378524585
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ALMOTRIPTAN MALATEApproval Type
Generic (ANDA)
FDA Application
ANDA205171FDA Approved
11/9/2015
TE Code
AB
On Market Since
11/10/2015
Pharmacological Classes
Price Statistics
The NADAC for ALMOTRIPTAN MALATE 6.25 MG TAB has been published 251 times since Oct 19, 2016, and over the history we have for it it has declined 47.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $16.5091 per EA |
|---|---|
| All-time high | $31.1593 (Nov 15, 2017) |
| All-time low | $14.9253 (Jul 17, 2024) |
| 52-week high | $23.5624 |
| 52-week low | $16.5091 |
| Median price | $20.2906 |
| Average price | $21.6828 |
| Largest weekly change | -45.1% (Jan 18, 2023) |
| Weeks tracked | 251 |
| Tracking since | Oct 19, 2016 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Almotriptan market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Mylan Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Almotriptan market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin-1b and Serotonin-1d Receptor Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ALMOTRIPTAN MALATE 6.25 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for ALMOTRIPTAN MALATE 6.25 MG TAB, manufactured by Mylan Pharmaceuticals Inc., is $16.5091 per EA (NDC 00378524585), effective Sep 30, 2026.
How has the price of ALMOTRIPTAN MALATE 6.25 MG TAB changed over time?
Over the history we have for it, the NADAC for ALMOTRIPTAN MALATE 6.25 MG TAB has declined 47.0%. It has been tracked across 251 weekly CMS publications since Oct 19, 2016.
What are the highest and lowest recorded NADAC prices for ALMOTRIPTAN MALATE 6.25 MG TAB?
Since Oct 19, 2016, the NADAC for ALMOTRIPTAN MALATE 6.25 MG TAB has ranged from a low of $14.9253 (Jul 17, 2024) to a high of $31.1593 (Nov 15, 2017), with a median of $20.2906 per EA.
Are there cheaper alternatives to ALMOTRIPTAN MALATE 6.25 MG TAB?
No other NADAC-published product currently shares the active ingredient and strength of ALMOTRIPTAN MALATE 6.25 MG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ALMOTRIPTAN MALATE 6.25 MG TAB?
ALMOTRIPTAN MALATE 6.25 MG TAB (NDC 00378524585) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.